RSV pre-fusion F protein enhances the G protein antibody and anti-infectious responses
Abstract Respiratory syncytial virus (RSV) infection in children is the most common viral respiratory infection and can cause severe lung damage or death. There is no licensed vaccine for preventing RSV infection. Previously we demonstrated that an RSV vaccine, BARS13, consisting of recombinant G pr...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-12-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-022-00591-w |